19 GHP Healthcare and Pharmaceutical Awards 2025 disease. In parallel, digital audiometry is still vastly underutilised and traditional care models continue to dominate the space. To address this, hearX invests heavily in thoughtleadership, global awareness campaigns, and education to shift perceptions around hearing care and its relevance to broader health outcomes. It is also conducting local market research, expanding strategic partnerships, and refining infrastructure to enable easier digital adoption. By working closely with healthcare providers and researchers, the company is championing inclusive, tech-enabled care models that bring validated hearing care to more hands, with more affordability. Over the last 12 months, hearX achieved a major R&D milestone with the release of hearOAE, its new smartphone- and tabletbased otoacoustic emissions device. Unveiled at the 2024 AAA+HearTECH Expo, hearOAE is FDA-cleared and supports both Transient Evoked and Distortion Product screening and diagnostic testing. Its integration with hearX’s Health Information Management System enables secure, real-time device, user, and data management, enabling informed hearing care decisionmaking and follow-up care. Following five years of development, hearOAE will make hearing assessments significantly more affordable and accessible across key use cases, including newborn and elderly care, and in contexts requiring non-responsive testing and early intervention. Looking ahead, hearX eagerly anticipates the continuation of its research and development, seeking to design new products that will help businesses and practitioners save time and costs, whilst breaking accessibility barriers to hearing care for those who need it most. Behind this innovation is a mission-driven team with a clear goal: to make hearing care accessible to everyone, everywhere. Their continued investment in R&D, like the recent launch of hearOAE, and focus on supporting global partners with exceptional training, support, and data management, reflect hearX’s commitment to bold and scalable hearing care transformation. This unique combination of impact, usability, innovation, and global reach is what makes them a game-changer in the hearing health industry. Contact: Nicole Myburgh Company: hearX USA Inc Web Address: www.hearxgroup.com Founded in 2015, hearX is an industry-leading health technology company on a mission to make healthy hearing accessible to everyone, everywhere. Leveraging smart technology and data, the company has built a comprehensive suite of digital solutions designed to support hearing loss screening and monitoring for various settings worldwide, including clinical trials, healthcare, research, hearing conversation, and school and newborn screening. Across the wider healthcare and pharmaceutical sector, hearX stands out by solving one of the most under-addressed challenges in clinical research and care provision: timely hearing loss screening and monitoring. The company is deeply committed to creating meaningful change by ensuring that assessments are affordable, intuitive, and adaptable. Combining scientific research with agility and purpose, hearX is redefining how hearing care is delivered to diverse populations in clinics, research studies, and underserved communities. Untreated hearing loss impacts patient safety, quality of life, and can be a critical outcome in drug trials – particularly where ototoxicity is a known risk. hearX’s clinically validated, boothless technology eliminates the need for traditional infrastructure and extensive training, enabling fast, scalable, and accurate hearing testing in both centralised and remote settings. For clinical trials, this means more efficient participant monitoring, support with early detection of adverse effects, and greater accessibility – even in resource-limited environments. The company’s most notable strength lies in its ability to pair clinical validity with scalable, real-world impact. Its flagship product, hearTest, is a portable, boothless audiometry solution that enables accurate hearing assessments on a digital smart device. This product is portable, easy to use, and competitively priced, making it ideal for settings where traditional audiometry simply is not feasible. Through hearTest, hearX has removed the need for soundproofed booths, brought hearing testing to digital devices, and continues to enable offline testing with cloud-based data syncs and uploads – features that are especially revolutionary in low-resource environments. The company’s technology is trusted in more than 192 countries, with real-world results that demonstrate both efficiency and care improvement, supporting increased patient throughput and early hearing loss detection. The journey has not been without its challenges, and one of the biggest hurdles hearX faces has been shifting mindsets and raising awareness about the critical role hearing health plays in our overall wellbeing. Hearing loss remains largely underestimated despite its well-documented links to comorbidities, including cognitive decline, depression, dementia, and Alzheimer’s Hearing health is increasingly recognised as a vital component of overall wellbeing, with growing demand for accessible, high quality screening solutions across clinical and community settings. hearX® is a health technology company developing smart, scalable tools that support hearing care delivery worldwide through innovation, research, and strategic collaboration. Best Digital Hearing Health Assessment Solutions Provider 2025 & Best Digital Audiometry Solution 2025: hearTest hearX USA Inc
RkJQdWJsaXNoZXIy NTY1MjM3